Westaim Holdings Limited (formerly NUCRYST Pharmaceuticals Corp.)
Profile
Mailing Address: Fifth Avenue Place
12th Floor, 425 - 1st Street SW
Calgary, Alberta
T2P 3L8
Head Office Address: 212 King Street
Suite 201
Toronto, Ontario
M5H 1K5
Contact Name: Jeffrey Sarfin Principal Regulator: Ontario
Business e-mail address: jsarfin@westaim.com Short Form Prospectus Issuer: No
Telephone Number: 416 203-2253 Reporting Jurisdictions: Ceased Reporting
Fax Number: 416 203-0734 Stock Exchange: N/A
Date of Formation: Dec 18 1997 Stock Symbol:
Jurisdiction Where Formed: Alberta Auditor: Deloitte & Touche LLP
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: Transfer Agent: Computershare Trust Company of Canada
Financial Year-End: Dec 31 Size of Issuer (Assets): $100,000,001 to $500,000,000


View This Company's Documents